Dongkuk Steel Mill Co Ltd (001230)
Korea Stock Exchange · Korea · prices in KRW · close of 22 Oct 2026
Key indicators
| Last close | KRW 1,976.00 |
|---|---|
| 52-week range | 1,372.00 – 2,545.00 |
| Return, 1 month / 3 months | −7.0% / +21.5% |
| Return, 1 year / 3 years | +33.3% / +31.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 46.3% |
| Worst drawdown (1 year) | -29.3% |
| Average daily value traded | 1,091.81M KRW |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Dongkuk Steel Mill is a Korean steelmaker that produces steel plates and long steel products. Its plate mills supply shipbuilding and industrial customers, while its long-product lines make reinforcing bar and sections for construction work. The company operates steelworks in Korea and serves builders, shipyards and manufacturers at home and abroad. Its business centres on making and shaping steel for the construction and shipbuilding industries.
Dongkuk Steel Mill Co Ltd trades under the code 001230 on the Korea Stock Exchange in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Dongkuk Steel Mill Co Ltd (001230) trades on the Korea Stock Exchange in Korea. It last closed at KRW 1,976.00 on 22 October 2026.
Its price-based Market X-Ray is 78 out of 100 (a strong price profile), ranking 35 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.3% and over the last three months it rose 21.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 92 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.3% | ||
| From 52-week high | -13.9% | ||
| Momentum | 84 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 21.5% | ||
| 6-month return | -11.3% | ||
| 12-month return, skipping the last month | 43.4% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 46.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.3% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 1,091.81M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.3% |
|---|---|
| 1 month | −7.0% |
| 3 months | +21.5% |
| 6 months | −11.3% |
| 1 year | +33.3% |
| 3 years | +31.6% |
| 5 years | +35.1% |
Signals
| 50-day / 200-day average | 2,016.94 / 1,808.66 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 86.85 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Jun 2025 | KRW 100.0000 |
| 28 Mar 2025 | KRW 400.0000 |
| 27 Jun 2024 | KRW 100.0000 |
| 27 Dec 2023 | KRW 600.0000 |
| 28 Dec 2022 | KRW 500.0012 |
| 29 Dec 2021 | KRW 400.0009 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.